Preteen With Cystic Fibrosis (CF) Is Back to Active Life, Thanks to New Drug, Supportive Care Team
Cystic fibrosis drug helps preteen avoid lung transplant.
Cystic fibrosis drug helps preteen avoid lung transplant.
Giving a new cystic fibrosis medication to a pregnant woman who carries the gene for the disease was unexpectedly beneficial for her fetus, a Stanford Medicine team found.
Claire has cystic fibrosis, but new treatments that attack the disease at the genetic level are helping her live a full life.
Stanford University graduate and cystic fibrosis patient Mallory Smith lived life vibrantly until her death at age 25. She left behind a memoir, “Salt in My Soul – An Unfinished Life,” that reveals much about hope, love, care and chronic illness.
Today, on Rare Disease Day, we’re focusing on a lung condition that can be just as… Read more »
Stanford researchers have invented a new technique to detect cystic fibrosis in infants. The test, described in a paper published today in The Journal of Molecular Diagnostics, is more comprehensive, faster and cheaper than current newborn screening methods.
Lauren Catron, 26, credits the specialists at the Pulmonary and Cystic Fibrosis Center at Lucile Packard Children’s Hospital Stanford for keeping her alive.
Life expectancy for people with cystic fibrosis has improved dramatically in the last few decades, but those with CF still struggle with a very basic action: breathing easily. However, a new study indicates that a specific dietary supplement might stave off the decline in lung function that characterizes this genetic disease.
Doris Diaz battled with severe cystic fibrosis. After her double lung transplant, Doris is able to take deep breaths for the first time in her life.
“There’s nothing like having a bond with someone else who knows exactly what you’re going through.”